|
Delayed
Australian S.E.
04:36:45 16/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 189.76 AUD | +1.53% |
|
+3.30% | +10.00% |
| 10-14 | EU Accepts Sanofi's Concessions to End Antitrust Probe Over Vaccine Marketing -- Update | DJ |
| 10-14 | EU Accepts Sanofi's Concessions to Settle Antitrust Probe Over Vaccine Marketing | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 61.54B | |||||
| 1,077B | |||||
| 612B | |||||
| 501B | |||||
| 364B | |||||
| 353B |
- Stock Market
- Stocks
- CSL Stock
- Charts CSL Limited
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
